Mendel-Hartvig I, Frostell A, Nelson B D
Clin Exp Immunol. 1986 Nov;66(2):399-405.
The adenine nucleotide translocator protein (ANT) is the first well-characterized mitochondrial polypeptide to be identified as an antigen for antimitochondrial autoantibodies (AMA) in PBC sera. Because of the potential use for a highly purified antigen as a tool in studying the aetiology of PBC, we have undertaken an assessment of the quantitative importance of ANT as a PBC-specific mitochondrial antigen. Immunoblotting and ELISA techniques were used. Both methods reveal PBC antibodies against isolated rat liver ANT. However, competitive ELISA experiments using purified rat liver ANT as the competing antigen show that anti-ANT antibodies in PBC serum comprise only a fraction of the total AMA. Furthermore, both ELISA and immunoblotting experiments show that rat liver ANT is not a specific antigen for PBC autoantibodies. Sera from patients with SLE, chronic active hepatitis, and sera from normal, control patients, have nearly the same, or higher, ANT antibody titres. Thus, ANT is not a good candidate as an antigen for the diagnosis of PBC.
腺嘌呤核苷酸转运蛋白(ANT)是首个被明确鉴定为原发性胆汁性胆管炎(PBC)患者血清中线粒体自身抗体(AMA)抗原的线粒体多肽。鉴于高纯度抗原在研究PBC病因方面具有潜在用途,我们对ANT作为PBC特异性线粒体抗原的定量重要性进行了评估。采用了免疫印迹和酶联免疫吸附测定(ELISA)技术。两种方法均检测到PBC患者血清中针对分离的大鼠肝脏ANT的抗体。然而,使用纯化的大鼠肝脏ANT作为竞争抗原的竞争性ELISA实验表明,PBC血清中的抗ANT抗体仅占总AMA的一小部分。此外,ELISA和免疫印迹实验均表明,大鼠肝脏ANT并非PBC自身抗体的特异性抗原。系统性红斑狼疮(SLE)患者、慢性活动性肝炎患者以及正常对照患者血清中的ANT抗体滴度几乎相同或更高。因此,ANT并非诊断PBC的理想抗原候选物。